ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
62 announcements with these filters
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.
Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.
Advanced Enzyme Technologies received requests from four promoter group members to reclassify as 'Public' shareholders. These requests are pending board consideration.
Advanced Enzyme Technologies Ltd reported the daily buyback of 56,066 equity shares on September 17, 2026, at an average price of ₹289.48.
Advanced Enzyme Technologies bought back 55,665 shares on September 16, 2026, at an average price of ₹291.25 per share. Total cumulative buyback stands at 1,297,422 shares.
Advanced Enzyme Technologies bought back 53,607 shares on September 15, 2026, at an average price of ₹294.6372 per share, totaling approximately ₹1.58 Crore.
Advanced Enzyme Technologies bought 46,212 shares on September 09, 2026, at an average price of ₹299.5388 per share as part of its ongoing buyback programme.
Advanced Enzyme Technologies Ltd bought back 36,543 shares at an average price of ₹299.4999 on September 08, 2026, under its ongoing buyback program.
Advanced Enzyme Technologies extinguished 8,25,028 equity shares (face value ₹2) bought back in August 2026. The certificate confirms compliance with SEBI Buy-Back Regulations.
Advanced Enzyme Technologies Ltd reported the buyback of 31,197 equity shares on September 07, 2026. The average acquisition price was ₹295.9121 per share.
Advanced Enzyme Technologies received requests from five promoter group members to reclassify from 'Promoter Group' to 'Public' category under SEBI Regulation 31A.
Advanced Enzyme Technologies bought back 55,332 shares on September 04, 2026, at an average price of ₹297.9337 per share under its buyback program.
Advanced Enzyme Technologies bought back 31,571 equity shares at an average price of ₹295.39 per share, totaling ₹0.93 Crore on September 03, 2026.
Advanced Enzyme Technologies bought back 58,083 equity shares on September 02, 2026, at an average price of ₹295.3153 per share, totaling 9,41,885 cumulative shares.
Advanced Enzyme Technologies bought 58,774 shares at an average price of ₹296.05 on September 01, 2026. This daily update confirms the company's ongoing share buyback program.
Advanced Enzyme Technologies bought back 63,718 equity shares on August 31, 2026, at an average price of ₹297.65 per share under its buyback program.
Advanced Enzyme Technologies bought back 60,711 shares on August 28, 2026, for approximately ₹1.81 Crore. This daily report confirms ongoing share repurchase activity.
Advanced Enzyme Technologies Ltd bought back 68,248 equity shares on August 27, 2026, at an average price of ₹298.11, totaling approximately ₹2.03 Crore.
Advanced Enzyme Technologies bought back 72,807 shares at an average price of ₹303.25 each on August 25, 2026. This daily disclosure fulfills regulatory requirements.
Advanced Enzyme Technologies bought back 40,876 shares on August 24, 2026, at an average price of ₹302.78 per share. This is part of its ongoing buyback program.
Advanced Enzyme Technologies Ltd repurchased 91,757 equity shares on August 21, 2026, at an average price of ₹305.9378, totaling approximately ₹2.81 Crore.
Advanced Enzyme Technologies Ltd. bought back 88,274 equity shares at an average price of ₹308.7879 per share on August 20, 2026, under its buyback program.
Advanced Enzyme Technologies reported the buyback of 67,748 equity shares on August 19, 2026, at an average price of ₹305.05 per share.
Advanced Enzyme Technologies Ltd bought back 94,686 shares at an average price of ₹305.44 per share on August 18, 2026.
Advanced Enzyme Technologies bought back 65,252 shares on August 17, 2026, at an average price of ₹304.71 per share under its ongoing buyback program.
Advanced Enzyme Technologies bought back 1,10,951 equity shares on August 14, 2026, at an average price of ₹303.80 per share.
Q1FY27 was muted with flat revenue growth and EBITDA contraction due to higher energy costs and standard revenue reversal accounting. Management maintains double-digit growth targets despite current geopolitical and US-market headwinds.